XML 84 R72.htm IDEA: XBRL DOCUMENT v3.20.4
Business Segments (Information on Operating and Reportable Segments) (Details) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2020
Dec. 31, 2019
Segment Reporting Information, Profit (Loss):        
Total revenues $ 238,788 $ 241,552 $ 705,604 $ 711,775
Cost of sales 99,901 104,057 295,188 303,462
Gross profit 138,887 137,495 410,416 408,313
Advertising and marketing 38,081 33,559 104,172 107,027
Contribution margin 100,806 103,936 306,244 301,286
Other operating expenses 27,363 27,532 79,779 84,048
Operating income 73,443 76,404 226,465 217,238
North American OTC Healthcare        
Segment Reporting Information, Profit (Loss):        
Total revenues 210,618 214,892 637,851 639,554
International OTC Healthcare        
Segment Reporting Information, Profit (Loss):        
Total revenues 28,170 26,660 67,753 72,221
Operating Segments | North American OTC Healthcare        
Segment Reporting Information, Profit (Loss):        
Total revenues 210,618 214,892 637,851 639,554
Cost of sales 88,883 93,937 267,779 275,679
Gross profit 121,735 120,955 370,072 363,875
Advertising and marketing 32,859 29,025 91,553 94,634
Contribution margin 88,876 91,930 278,519 269,241
Operating Segments | International OTC Healthcare        
Segment Reporting Information, Profit (Loss):        
Total revenues 28,170 26,660 67,753 72,221
Cost of sales 11,018 10,120 27,409 27,783
Gross profit 17,152 16,540 40,344 44,438
Advertising and marketing 5,222 4,534 12,619 12,393
Contribution margin 11,930 12,006 27,725 32,045
Intersegment Eliminations | North American OTC Healthcare        
Segment Reporting Information, Profit (Loss):        
Total revenues $ 800 $ 600 $ 2,400 $ 2,100